Cellectis SA (CLLS)
3.89
-0.02
(-0.51%)
USD |
NASDAQ |
Apr 24, 16:00
3.93
+0.04
(+1.03%)
After-Hours: 20:00
Cellectis Market Cap : 391.30M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 1.088B |
| EDAP TMS SA | 120.69M |
| Sanofi | 114.09B |
| Akari Therapeutics Plc | 6.639M |
| Biodexa Pharmaceuticals Plc | 2.140M |
Market Cap Related Metrics
| PS Ratio | 5.362 |
| PEG Ratio | -0.0709 |
| Price to Book Value | 5.155 |
| Price | 3.89 |
| Earnings Yield | -17.41% |
| PEGY Ratio | -0.0709 |